Kultima K

Uncemented hip arthroplasty and denosumab: increased postoperative dipeptide concentrations and identification of potential new bone turnover biomarkers.

Kultima K, Ashtiani SH, Erngren I, ..., Mallmin H, Hailer NP

JBMR Plus 9 (7) ziaf091 [2025-07-00; online 2025-05-19]

Bioinformatics (NBIS) [Collaborative] Bioinformatics Support and Infrastructure [Collaborative] Bioinformatics Support, Infrastructure and Training [Collaborative]

Associations of PFAS and OH-PCBs with risk of multiple sclerosis onset and disability worsening.

Vaivade A, Erngren I, Carlsson H, ..., Burman J, Kultima K

Nat Commun 16 (1) 2014 [2025-02-27; online 2025-02-27]

Bioinformatics (NBIS) [Collaborative] Bioinformatics Long-term Support WABI [Collaborative] Bioinformatics Support, Infrastructure and Training [Collaborative]

Effects of denosumab treatment on the expression of receptor activator of nuclear kappa-B ligand (RANKL) and TNF-receptor TNFRSF9 after total hip arthroplasty-results from a randomized placebo-controlled clinical trial.

Sköld C, Kultima K, Freyhult E, ..., Hailer NP, Mallmin H

Osteoporos Int 33 (9) 1-8 [2022-09-00; online 2022-05-24]

Affinity Proteomics Uppsala [Service]

Albumin Urinary Excretion Is Associated with Increased Levels of Urinary Chemokines, Cytokines, and Growth Factors Levels in Humans.

Fellström B, Helmersson-Karlqvist J, Lind L, ..., Kultima K, Larsson A

Biomolecules 11 (3) - [2021-03-08; online 2021-03-08]

Affinity Proteomics Uppsala [Service]